Global Targeted Protein Degradation Drug Supply, Demand and Key Producers, 2024-2030
The global Targeted Protein Degradation Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Targeted Protein Degradation Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Protein Degradation Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Protein Degradation Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted Protein Degradation Drug total market, 2019-2030, (USD Million)
Global Targeted Protein Degradation Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Targeted Protein Degradation Drug total market, key domestic companies and share, (USD Million)
Global Targeted Protein Degradation Drug revenue by player and market share 2019-2024, (USD Million)
Global Targeted Protein Degradation Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Targeted Protein Degradation Drug total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Targeted Protein Degradation Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, Nurix and Kymera Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Protein Degradation Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Targeted Protein Degradation Drug Market, By Region:
1. How big is the global Targeted Protein Degradation Drug market?
2. What is the demand of the global Targeted Protein Degradation Drug market?
3. What is the year over year growth of the global Targeted Protein Degradation Drug market?
4. What is the total value of the global Targeted Protein Degradation Drug market?
5. Who are the major players in the global Targeted Protein Degradation Drug market?
This report studies the global Targeted Protein Degradation Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Protein Degradation Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Protein Degradation Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted Protein Degradation Drug total market, 2019-2030, (USD Million)
Global Targeted Protein Degradation Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Targeted Protein Degradation Drug total market, key domestic companies and share, (USD Million)
Global Targeted Protein Degradation Drug revenue by player and market share 2019-2024, (USD Million)
Global Targeted Protein Degradation Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Targeted Protein Degradation Drug total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Targeted Protein Degradation Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, Nurix and Kymera Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Protein Degradation Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Targeted Protein Degradation Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- PROTAC
- Molecular Glue
- Cancer
- Autoimmune Diseases
- Other
- Arvinas
- Kangpu Biopharmaceuticals
- Ranok Therapeutics
- Accutar Biotechnology
- BeiGene Ltd.
- Hinova Pharmaceuticals
- Haisco Pharmaceutical
- Nurix
- Kymera Therapeutics
- C4 Therapeutics
1. How big is the global Targeted Protein Degradation Drug market?
2. What is the demand of the global Targeted Protein Degradation Drug market?
3. What is the year over year growth of the global Targeted Protein Degradation Drug market?
4. What is the total value of the global Targeted Protein Degradation Drug market?
5. Who are the major players in the global Targeted Protein Degradation Drug market?
1 SUPPLY SUMMARY
1.1 Targeted Protein Degradation Drug Introduction
1.2 World Targeted Protein Degradation Drug Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Targeted Protein Degradation Drug Total Market by Region (by Headquarter Location)
1.3.1 World Targeted Protein Degradation Drug Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.3 China Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.4 Europe Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.5 Japan Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.6 South Korea Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.7 ASEAN Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.8 India Targeted Protein Degradation Drug Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Protein Degradation Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Protein Degradation Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.2 World Targeted Protein Degradation Drug Consumption Value by Region
2.2.1 World Targeted Protein Degradation Drug Consumption Value by Region (2019-2024)
2.2.2 World Targeted Protein Degradation Drug Consumption Value Forecast by Region (2025-2030)
2.3 United States Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.4 China Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.5 Europe Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.6 Japan Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.7 South Korea Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.8 ASEAN Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.9 India Targeted Protein Degradation Drug Consumption Value (2019-2030)
3 WORLD TARGETED PROTEIN DEGRADATION DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Targeted Protein Degradation Drug Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Targeted Protein Degradation Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Targeted Protein Degradation Drug in 2023
3.2.3 Global Concentration Ratios (CR8) for Targeted Protein Degradation Drug in 2023
3.3 Targeted Protein Degradation Drug Company Evaluation Quadrant
3.4 Targeted Protein Degradation Drug Market: Overall Company Footprint Analysis
3.4.1 Targeted Protein Degradation Drug Market: Region Footprint
3.4.2 Targeted Protein Degradation Drug Market: Company Product Type Footprint
3.4.3 Targeted Protein Degradation Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Targeted Protein Degradation Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Targeted Protein Degradation Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Targeted Protein Degradation Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Targeted Protein Degradation Drug Consumption Value Comparison
4.2.1 United States VS China: Targeted Protein Degradation Drug Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Targeted Protein Degradation Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Targeted Protein Degradation Drug Companies and Market Share, 2019-2024
4.3.1 United States Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024)
4.4 China Based Companies Targeted Protein Degradation Drug Revenue and Market Share, 2019-2024
4.4.1 China Based Targeted Protein Degradation Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024)
4.5 Rest of World Based Targeted Protein Degradation Drug Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Protein Degradation Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 PROTAC
5.2.2 Molecular Glue
5.3 Market Segment by Type
5.3.1 World Targeted Protein Degradation Drug Market Size by Type (2019-2024)
5.3.2 World Targeted Protein Degradation Drug Market Size by Type (2025-2030)
5.3.3 World Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Protein Degradation Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Autoimmune Diseases
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Targeted Protein Degradation Drug Market Size by Application (2019-2024)
6.3.2 World Targeted Protein Degradation Drug Market Size by Application (2025-2030)
6.3.3 World Targeted Protein Degradation Drug Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Arvinas
7.1.1 Arvinas Details
7.1.2 Arvinas Major Business
7.1.3 Arvinas Targeted Protein Degradation Drug Product and Services
7.1.4 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Arvinas Recent Developments/Updates
7.1.6 Arvinas Competitive Strengths & Weaknesses
7.2 Kangpu Biopharmaceuticals
7.2.1 Kangpu Biopharmaceuticals Details
7.2.2 Kangpu Biopharmaceuticals Major Business
7.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Services
7.2.4 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Kangpu Biopharmaceuticals Recent Developments/Updates
7.2.6 Kangpu Biopharmaceuticals Competitive Strengths & Weaknesses
7.3 Ranok Therapeutics
7.3.1 Ranok Therapeutics Details
7.3.2 Ranok Therapeutics Major Business
7.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Product and Services
7.3.4 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Ranok Therapeutics Recent Developments/Updates
7.3.6 Ranok Therapeutics Competitive Strengths & Weaknesses
7.4 Accutar Biotechnology
7.4.1 Accutar Biotechnology Details
7.4.2 Accutar Biotechnology Major Business
7.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Product and Services
7.4.4 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Accutar Biotechnology Recent Developments/Updates
7.4.6 Accutar Biotechnology Competitive Strengths & Weaknesses
7.5 BeiGene Ltd.
7.5.1 BeiGene Ltd. Details
7.5.2 BeiGene Ltd. Major Business
7.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Product and Services
7.5.4 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 BeiGene Ltd. Recent Developments/Updates
7.5.6 BeiGene Ltd. Competitive Strengths & Weaknesses
7.6 Hinova Pharmaceuticals
7.6.1 Hinova Pharmaceuticals Details
7.6.2 Hinova Pharmaceuticals Major Business
7.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Services
7.6.4 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Hinova Pharmaceuticals Recent Developments/Updates
7.6.6 Hinova Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Haisco Pharmaceutical
7.7.1 Haisco Pharmaceutical Details
7.7.2 Haisco Pharmaceutical Major Business
7.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Services
7.7.4 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Haisco Pharmaceutical Recent Developments/Updates
7.7.6 Haisco Pharmaceutical Competitive Strengths & Weaknesses
7.8 Nurix
7.8.1 Nurix Details
7.8.2 Nurix Major Business
7.8.3 Nurix Targeted Protein Degradation Drug Product and Services
7.8.4 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Nurix Recent Developments/Updates
7.8.6 Nurix Competitive Strengths & Weaknesses
7.9 Kymera Therapeutics
7.9.1 Kymera Therapeutics Details
7.9.2 Kymera Therapeutics Major Business
7.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Product and Services
7.9.4 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Kymera Therapeutics Recent Developments/Updates
7.9.6 Kymera Therapeutics Competitive Strengths & Weaknesses
7.10 C4 Therapeutics
7.10.1 C4 Therapeutics Details
7.10.2 C4 Therapeutics Major Business
7.10.3 C4 Therapeutics Targeted Protein Degradation Drug Product and Services
7.10.4 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 C4 Therapeutics Recent Developments/Updates
7.10.6 C4 Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Targeted Protein Degradation Drug Industry Chain
8.2 Targeted Protein Degradation Drug Upstream Analysis
8.3 Targeted Protein Degradation Drug Midstream Analysis
8.4 Targeted Protein Degradation Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Targeted Protein Degradation Drug Introduction
1.2 World Targeted Protein Degradation Drug Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Targeted Protein Degradation Drug Total Market by Region (by Headquarter Location)
1.3.1 World Targeted Protein Degradation Drug Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.3 China Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.4 Europe Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.5 Japan Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.6 South Korea Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.7 ASEAN Targeted Protein Degradation Drug Market Size (2019-2030)
1.3.8 India Targeted Protein Degradation Drug Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Protein Degradation Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Protein Degradation Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.2 World Targeted Protein Degradation Drug Consumption Value by Region
2.2.1 World Targeted Protein Degradation Drug Consumption Value by Region (2019-2024)
2.2.2 World Targeted Protein Degradation Drug Consumption Value Forecast by Region (2025-2030)
2.3 United States Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.4 China Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.5 Europe Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.6 Japan Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.7 South Korea Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.8 ASEAN Targeted Protein Degradation Drug Consumption Value (2019-2030)
2.9 India Targeted Protein Degradation Drug Consumption Value (2019-2030)
3 WORLD TARGETED PROTEIN DEGRADATION DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Targeted Protein Degradation Drug Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Targeted Protein Degradation Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Targeted Protein Degradation Drug in 2023
3.2.3 Global Concentration Ratios (CR8) for Targeted Protein Degradation Drug in 2023
3.3 Targeted Protein Degradation Drug Company Evaluation Quadrant
3.4 Targeted Protein Degradation Drug Market: Overall Company Footprint Analysis
3.4.1 Targeted Protein Degradation Drug Market: Region Footprint
3.4.2 Targeted Protein Degradation Drug Market: Company Product Type Footprint
3.4.3 Targeted Protein Degradation Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Targeted Protein Degradation Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Targeted Protein Degradation Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Targeted Protein Degradation Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Targeted Protein Degradation Drug Consumption Value Comparison
4.2.1 United States VS China: Targeted Protein Degradation Drug Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Targeted Protein Degradation Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Targeted Protein Degradation Drug Companies and Market Share, 2019-2024
4.3.1 United States Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024)
4.4 China Based Companies Targeted Protein Degradation Drug Revenue and Market Share, 2019-2024
4.4.1 China Based Targeted Protein Degradation Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024)
4.5 Rest of World Based Targeted Protein Degradation Drug Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Protein Degradation Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 PROTAC
5.2.2 Molecular Glue
5.3 Market Segment by Type
5.3.1 World Targeted Protein Degradation Drug Market Size by Type (2019-2024)
5.3.2 World Targeted Protein Degradation Drug Market Size by Type (2025-2030)
5.3.3 World Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Protein Degradation Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Autoimmune Diseases
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Targeted Protein Degradation Drug Market Size by Application (2019-2024)
6.3.2 World Targeted Protein Degradation Drug Market Size by Application (2025-2030)
6.3.3 World Targeted Protein Degradation Drug Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Arvinas
7.1.1 Arvinas Details
7.1.2 Arvinas Major Business
7.1.3 Arvinas Targeted Protein Degradation Drug Product and Services
7.1.4 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Arvinas Recent Developments/Updates
7.1.6 Arvinas Competitive Strengths & Weaknesses
7.2 Kangpu Biopharmaceuticals
7.2.1 Kangpu Biopharmaceuticals Details
7.2.2 Kangpu Biopharmaceuticals Major Business
7.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Services
7.2.4 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Kangpu Biopharmaceuticals Recent Developments/Updates
7.2.6 Kangpu Biopharmaceuticals Competitive Strengths & Weaknesses
7.3 Ranok Therapeutics
7.3.1 Ranok Therapeutics Details
7.3.2 Ranok Therapeutics Major Business
7.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Product and Services
7.3.4 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Ranok Therapeutics Recent Developments/Updates
7.3.6 Ranok Therapeutics Competitive Strengths & Weaknesses
7.4 Accutar Biotechnology
7.4.1 Accutar Biotechnology Details
7.4.2 Accutar Biotechnology Major Business
7.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Product and Services
7.4.4 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Accutar Biotechnology Recent Developments/Updates
7.4.6 Accutar Biotechnology Competitive Strengths & Weaknesses
7.5 BeiGene Ltd.
7.5.1 BeiGene Ltd. Details
7.5.2 BeiGene Ltd. Major Business
7.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Product and Services
7.5.4 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 BeiGene Ltd. Recent Developments/Updates
7.5.6 BeiGene Ltd. Competitive Strengths & Weaknesses
7.6 Hinova Pharmaceuticals
7.6.1 Hinova Pharmaceuticals Details
7.6.2 Hinova Pharmaceuticals Major Business
7.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Services
7.6.4 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Hinova Pharmaceuticals Recent Developments/Updates
7.6.6 Hinova Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Haisco Pharmaceutical
7.7.1 Haisco Pharmaceutical Details
7.7.2 Haisco Pharmaceutical Major Business
7.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Services
7.7.4 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Haisco Pharmaceutical Recent Developments/Updates
7.7.6 Haisco Pharmaceutical Competitive Strengths & Weaknesses
7.8 Nurix
7.8.1 Nurix Details
7.8.2 Nurix Major Business
7.8.3 Nurix Targeted Protein Degradation Drug Product and Services
7.8.4 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Nurix Recent Developments/Updates
7.8.6 Nurix Competitive Strengths & Weaknesses
7.9 Kymera Therapeutics
7.9.1 Kymera Therapeutics Details
7.9.2 Kymera Therapeutics Major Business
7.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Product and Services
7.9.4 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Kymera Therapeutics Recent Developments/Updates
7.9.6 Kymera Therapeutics Competitive Strengths & Weaknesses
7.10 C4 Therapeutics
7.10.1 C4 Therapeutics Details
7.10.2 C4 Therapeutics Major Business
7.10.3 C4 Therapeutics Targeted Protein Degradation Drug Product and Services
7.10.4 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 C4 Therapeutics Recent Developments/Updates
7.10.6 C4 Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Targeted Protein Degradation Drug Industry Chain
8.2 Targeted Protein Degradation Drug Upstream Analysis
8.3 Targeted Protein Degradation Drug Midstream Analysis
8.4 Targeted Protein Degradation Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Targeted Protein Degradation Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Targeted Protein Degradation Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Targeted Protein Degradation Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Targeted Protein Degradation Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Targeted Protein Degradation Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Targeted Protein Degradation Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Targeted Protein Degradation Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Targeted Protein Degradation Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Targeted Protein Degradation Drug Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Targeted Protein Degradation Drug Players in 2023
Table 12. World Targeted Protein Degradation Drug Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Targeted Protein Degradation Drug Company Evaluation Quadrant
Table 14. Head Office of Key Targeted Protein Degradation Drug Player
Table 15. Targeted Protein Degradation Drug Market: Company Product Type Footprint
Table 16. Targeted Protein Degradation Drug Market: Company Product Application Footprint
Table 17. Targeted Protein Degradation Drug Mergers & Acquisitions Activity
Table 18. United States VS China Targeted Protein Degradation Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Targeted Protein Degradation Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Targeted Protein Degradation Drug Revenue Market Share (2019-2024)
Table 23. China Based Targeted Protein Degradation Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Targeted Protein Degradation Drug Revenue Market Share (2019-2024)
Table 26. Rest of World Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Targeted Protein Degradation Drug Revenue Market Share (2019-2024)
Table 29. World Targeted Protein Degradation Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Targeted Protein Degradation Drug Market Size by Type (2019-2024) & (USD Million)
Table 31. World Targeted Protein Degradation Drug Market Size by Type (2025-2030) & (USD Million)
Table 32. World Targeted Protein Degradation Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Targeted Protein Degradation Drug Market Size by Application (2019-2024) & (USD Million)
Table 34. World Targeted Protein Degradation Drug Market Size by Application (2025-2030) & (USD Million)
Table 35. Arvinas Basic Information, Area Served and Competitors
Table 36. Arvinas Major Business
Table 37. Arvinas Targeted Protein Degradation Drug Product and Services
Table 38. Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Arvinas Recent Developments/Updates
Table 40. Arvinas Competitive Strengths & Weaknesses
Table 41. Kangpu Biopharmaceuticals Basic Information, Area Served and Competitors
Table 42. Kangpu Biopharmaceuticals Major Business
Table 43. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Services
Table 44. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Kangpu Biopharmaceuticals Recent Developments/Updates
Table 46. Kangpu Biopharmaceuticals Competitive Strengths & Weaknesses
Table 47. Ranok Therapeutics Basic Information, Area Served and Competitors
Table 48. Ranok Therapeutics Major Business
Table 49. Ranok Therapeutics Targeted Protein Degradation Drug Product and Services
Table 50. Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Ranok Therapeutics Recent Developments/Updates
Table 52. Ranok Therapeutics Competitive Strengths & Weaknesses
Table 53. Accutar Biotechnology Basic Information, Area Served and Competitors
Table 54. Accutar Biotechnology Major Business
Table 55. Accutar Biotechnology Targeted Protein Degradation Drug Product and Services
Table 56. Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Accutar Biotechnology Recent Developments/Updates
Table 58. Accutar Biotechnology Competitive Strengths & Weaknesses
Table 59. BeiGene Ltd. Basic Information, Area Served and Competitors
Table 60. BeiGene Ltd. Major Business
Table 61. BeiGene Ltd. Targeted Protein Degradation Drug Product and Services
Table 62. BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. BeiGene Ltd. Recent Developments/Updates
Table 64. BeiGene Ltd. Competitive Strengths & Weaknesses
Table 65. Hinova Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. Hinova Pharmaceuticals Major Business
Table 67. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Services
Table 68. Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Hinova Pharmaceuticals Recent Developments/Updates
Table 70. Hinova Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Haisco Pharmaceutical Basic Information, Area Served and Competitors
Table 72. Haisco Pharmaceutical Major Business
Table 73. Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Services
Table 74. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Haisco Pharmaceutical Recent Developments/Updates
Table 76. Haisco Pharmaceutical Competitive Strengths & Weaknesses
Table 77. Nurix Basic Information, Area Served and Competitors
Table 78. Nurix Major Business
Table 79. Nurix Targeted Protein Degradation Drug Product and Services
Table 80. Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Nurix Recent Developments/Updates
Table 82. Nurix Competitive Strengths & Weaknesses
Table 83. Kymera Therapeutics Basic Information, Area Served and Competitors
Table 84. Kymera Therapeutics Major Business
Table 85. Kymera Therapeutics Targeted Protein Degradation Drug Product and Services
Table 86. Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Kymera Therapeutics Recent Developments/Updates
Table 88. C4 Therapeutics Basic Information, Area Served and Competitors
Table 89. C4 Therapeutics Major Business
Table 90. C4 Therapeutics Targeted Protein Degradation Drug Product and Services
Table 91. C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 92. Global Key Players of Targeted Protein Degradation Drug Upstream (Raw Materials)
Table 93. Targeted Protein Degradation Drug Typical Customers
List of Figure
Figure 1. Targeted Protein Degradation Drug Picture
Figure 2. World Targeted Protein Degradation Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Targeted Protein Degradation Drug Total Market Size (2019-2030) & (USD Million)
Figure 4. World Targeted Protein Degradation Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Targeted Protein Degradation Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 13. Targeted Protein Degradation Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 16. World Targeted Protein Degradation Drug Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. China Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. India Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Targeted Protein Degradation Drug by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Targeted Protein Degradation Drug Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Targeted Protein Degradation Drug Markets in 2023
Figure 27. United States VS China: Targeted Protein Degradation Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Targeted Protein Degradation Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Targeted Protein Degradation Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Targeted Protein Degradation Drug Market Size Market Share by Type in 2023
Figure 31. PROTAC
Figure 32. Molecular Glue
Figure 33. World Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2030)
Figure 34. World Targeted Protein Degradation Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Targeted Protein Degradation Drug Market Size Market Share by Application in 2023
Figure 36. Cancer
Figure 37. Autoimmune Diseases
Figure 38. Other
Figure 39. Targeted Protein Degradation Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Targeted Protein Degradation Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Targeted Protein Degradation Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Targeted Protein Degradation Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Targeted Protein Degradation Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Targeted Protein Degradation Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Targeted Protein Degradation Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Targeted Protein Degradation Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Targeted Protein Degradation Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Targeted Protein Degradation Drug Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Targeted Protein Degradation Drug Players in 2023
Table 12. World Targeted Protein Degradation Drug Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Targeted Protein Degradation Drug Company Evaluation Quadrant
Table 14. Head Office of Key Targeted Protein Degradation Drug Player
Table 15. Targeted Protein Degradation Drug Market: Company Product Type Footprint
Table 16. Targeted Protein Degradation Drug Market: Company Product Application Footprint
Table 17. Targeted Protein Degradation Drug Mergers & Acquisitions Activity
Table 18. United States VS China Targeted Protein Degradation Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Targeted Protein Degradation Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Targeted Protein Degradation Drug Revenue Market Share (2019-2024)
Table 23. China Based Targeted Protein Degradation Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Targeted Protein Degradation Drug Revenue Market Share (2019-2024)
Table 26. Rest of World Based Targeted Protein Degradation Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Targeted Protein Degradation Drug Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Targeted Protein Degradation Drug Revenue Market Share (2019-2024)
Table 29. World Targeted Protein Degradation Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Targeted Protein Degradation Drug Market Size by Type (2019-2024) & (USD Million)
Table 31. World Targeted Protein Degradation Drug Market Size by Type (2025-2030) & (USD Million)
Table 32. World Targeted Protein Degradation Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Targeted Protein Degradation Drug Market Size by Application (2019-2024) & (USD Million)
Table 34. World Targeted Protein Degradation Drug Market Size by Application (2025-2030) & (USD Million)
Table 35. Arvinas Basic Information, Area Served and Competitors
Table 36. Arvinas Major Business
Table 37. Arvinas Targeted Protein Degradation Drug Product and Services
Table 38. Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Arvinas Recent Developments/Updates
Table 40. Arvinas Competitive Strengths & Weaknesses
Table 41. Kangpu Biopharmaceuticals Basic Information, Area Served and Competitors
Table 42. Kangpu Biopharmaceuticals Major Business
Table 43. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Services
Table 44. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Kangpu Biopharmaceuticals Recent Developments/Updates
Table 46. Kangpu Biopharmaceuticals Competitive Strengths & Weaknesses
Table 47. Ranok Therapeutics Basic Information, Area Served and Competitors
Table 48. Ranok Therapeutics Major Business
Table 49. Ranok Therapeutics Targeted Protein Degradation Drug Product and Services
Table 50. Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Ranok Therapeutics Recent Developments/Updates
Table 52. Ranok Therapeutics Competitive Strengths & Weaknesses
Table 53. Accutar Biotechnology Basic Information, Area Served and Competitors
Table 54. Accutar Biotechnology Major Business
Table 55. Accutar Biotechnology Targeted Protein Degradation Drug Product and Services
Table 56. Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Accutar Biotechnology Recent Developments/Updates
Table 58. Accutar Biotechnology Competitive Strengths & Weaknesses
Table 59. BeiGene Ltd. Basic Information, Area Served and Competitors
Table 60. BeiGene Ltd. Major Business
Table 61. BeiGene Ltd. Targeted Protein Degradation Drug Product and Services
Table 62. BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. BeiGene Ltd. Recent Developments/Updates
Table 64. BeiGene Ltd. Competitive Strengths & Weaknesses
Table 65. Hinova Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. Hinova Pharmaceuticals Major Business
Table 67. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Services
Table 68. Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Hinova Pharmaceuticals Recent Developments/Updates
Table 70. Hinova Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Haisco Pharmaceutical Basic Information, Area Served and Competitors
Table 72. Haisco Pharmaceutical Major Business
Table 73. Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Services
Table 74. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Haisco Pharmaceutical Recent Developments/Updates
Table 76. Haisco Pharmaceutical Competitive Strengths & Weaknesses
Table 77. Nurix Basic Information, Area Served and Competitors
Table 78. Nurix Major Business
Table 79. Nurix Targeted Protein Degradation Drug Product and Services
Table 80. Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Nurix Recent Developments/Updates
Table 82. Nurix Competitive Strengths & Weaknesses
Table 83. Kymera Therapeutics Basic Information, Area Served and Competitors
Table 84. Kymera Therapeutics Major Business
Table 85. Kymera Therapeutics Targeted Protein Degradation Drug Product and Services
Table 86. Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Kymera Therapeutics Recent Developments/Updates
Table 88. C4 Therapeutics Basic Information, Area Served and Competitors
Table 89. C4 Therapeutics Major Business
Table 90. C4 Therapeutics Targeted Protein Degradation Drug Product and Services
Table 91. C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 92. Global Key Players of Targeted Protein Degradation Drug Upstream (Raw Materials)
Table 93. Targeted Protein Degradation Drug Typical Customers
List of Figure
Figure 1. Targeted Protein Degradation Drug Picture
Figure 2. World Targeted Protein Degradation Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Targeted Protein Degradation Drug Total Market Size (2019-2030) & (USD Million)
Figure 4. World Targeted Protein Degradation Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Targeted Protein Degradation Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Targeted Protein Degradation Drug Revenue (2019-2030) & (USD Million)
Figure 13. Targeted Protein Degradation Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 16. World Targeted Protein Degradation Drug Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. China Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. India Targeted Protein Degradation Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Targeted Protein Degradation Drug by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Targeted Protein Degradation Drug Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Targeted Protein Degradation Drug Markets in 2023
Figure 27. United States VS China: Targeted Protein Degradation Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Targeted Protein Degradation Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Targeted Protein Degradation Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Targeted Protein Degradation Drug Market Size Market Share by Type in 2023
Figure 31. PROTAC
Figure 32. Molecular Glue
Figure 33. World Targeted Protein Degradation Drug Market Size Market Share by Type (2019-2030)
Figure 34. World Targeted Protein Degradation Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Targeted Protein Degradation Drug Market Size Market Share by Application in 2023
Figure 36. Cancer
Figure 37. Autoimmune Diseases
Figure 38. Other
Figure 39. Targeted Protein Degradation Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
